Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Metastatic Castration Resistant Prostate Cancer (mCRPC) × CX 5461 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Burkitt Lymphoma 1

Interventions

talazoparib 1 olaparib 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 CX 5461 1 BAY 2315497 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05425862 2023-12-11

REPAIR

Peter MacCallum Cancer Centre, Australia

Phase 1 Suspended

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡